<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04951752</url>
  </required_header>
  <id_info>
    <org_study_id>SOPRE-001</org_study_id>
    <nct_id>NCT04951752</nct_id>
  </id_info>
  <brief_title>Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery</brief_title>
  <acronym>TQL_PACU</acronym>
  <official_title>Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery: a Single-centre, Retrospective, Observational Study Based on Five Selected Randomised Controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will review data collected in 5 previously completed randomised controlled trials&#xD;
      with a new primary outcome: to assess whether administration of the transmuscular quadratus&#xD;
      lumborum block has an impact on the time an individual patient stays in the postanaesthesia&#xD;
      care unit and how much opioid is consumed during this specified time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of recovery</measure>
    <time_frame>0-300 minutes</time_frame>
    <description>Minutes from arrival in PACU to completed recovery (arrival until ready for departure)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total time spent in recovery</measure>
    <time_frame>0-300 minutes</time_frame>
    <description>Minutes from arrival in PACU to actual departure time (arrival until actual departure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of stay at PACU after completed recovery</measure>
    <time_frame>0-300 minutes</time_frame>
    <description>Minutes from completed recovery to actual departure from PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid consumption in PACU</measure>
    <time_frame>0-300 minutes</time_frame>
    <description>Total amount of opioid administered, converted to Oral Morphine Equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest pain score in PACU</measure>
    <time_frame>0-300 minutes</time_frame>
    <description>Highest reported Numeric Rating Scale of pain during stay in recovery</description>
  </secondary_outcome>
  <number_of_groups>10</number_of_groups>
  <enrollment type="Actual">307</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Hemicolectomy, Active treatment</arm_group_label>
    <description>2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hemicolectomy, Placebo treatment</arm_group_label>
    <description>2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nephrectomy, Active treatment</arm_group_label>
    <description>2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nephrectomy, Placebo treatment</arm_group_label>
    <description>2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous nephrolithotomy, Active treatment</arm_group_label>
    <description>1x30mL 0.75% Ropivacaine administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous nephrolithotomy, Placebo treatment</arm_group_label>
    <description>1x30mL isotonic saline administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterectomy, Active treatment</arm_group_label>
    <description>2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterectomy, Placebo treatment</arm_group_label>
    <description>2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elective Caesarean section, Active treatment</arm_group_label>
    <description>2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elective Caesarean section, Placebo treatment</arm_group_label>
    <description>2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine injection</intervention_name>
    <description>Transmuscular quadratus lumborum block - active</description>
    <arm_group_label>Elective Caesarean section, Active treatment</arm_group_label>
    <arm_group_label>Hemicolectomy, Active treatment</arm_group_label>
    <arm_group_label>Hysterectomy, Active treatment</arm_group_label>
    <arm_group_label>Nephrectomy, Active treatment</arm_group_label>
    <arm_group_label>Percutaneous nephrolithotomy, Active treatment</arm_group_label>
    <other_name>Transmuscular quadratus lumborum block</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery (hemicolectomy, nephrectomy, percutaneous&#xD;
        nephrolithiotomy, hysterectomy of caesarean section).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Elective Surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to cooperate&#xD;
&#xD;
          -  Allergy to local anaesthetics or opioids&#xD;
&#xD;
          -  Inability to understand Danish&#xD;
&#xD;
          -  Regular intake of opioids&#xD;
&#xD;
          -  Local infection at site of injection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Børglum Neimann, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Associate Professor, Zealand University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zealand University Hospital</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Dam M, Hansen C, Poulsen TD, Azawi NH, Laier GH, Wolmarans M, Chan V, Bendtsen TF, Børglum J. Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy. Reg Anesth Pain Med. 2021 Jan;46(1):18-24. doi: 10.1136/rapm-2020-101745. Epub 2020 Oct 26.</citation>
    <PMID>33106280</PMID>
  </reference>
  <reference>
    <citation>Hansen CK, Dam M, Steingrimsdottir GE, Laier GH, Lebech M, Poulsen TD, Chan VWS, Wolmarans M, Bendtsen TF, Børglum J. Ultrasound-guided transmuscular quadratus lumborum block for elective cesarean section significantly reduces postoperative opioid consumption and prolongs time to first opioid request: a double-blind randomized trial. Reg Anesth Pain Med. 2019 Jul 14. pii: rapm-2019-100540. doi: 10.1136/rapm-2019-100540. [Epub ahead of print]</citation>
    <PMID>31308263</PMID>
  </reference>
  <results_reference>
    <citation>Dam M, Hansen CK, Poulsen TD, Azawi NH, Wolmarans M, Chan V, Laier GH, Bendtsen TF, Børglum J. Transmuscular quadratus lumborum block for percutaneous nephrolithotomy reduces opioid consumption and speeds ambulation and discharge from hospital: a single centre randomised controlled trial. Br J Anaesth. 2019 Aug;123(2):e350-e358. doi: 10.1016/j.bja.2019.04.054. Epub 2019 May 30.</citation>
    <PMID>31153628</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data will be shared upon reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

